Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.52 |
| ▸ | LNPEP | Q9UIQ6 | 8/20 | 0.51 |
| ▸ | ANPEP | P15144 | 3/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.48 |
| ▸ | F2 | P00734 | 4/20 | 0.47 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.47 |
| ▸ | REN | P00797 | 1/20 | 0.47 |
| ▸ | DPP3 | Q9NY33 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9407096 | 1.00 | SLC6A2 (0.52) | SLC6A2LNPEPANPEPOPRM1OPRD1 | |
| SCHEMBL31366723 | 0.91 | LNPEP (0.54) | LNPEPANPEPOPRD1F2 | |
| SCHEMBL9407086 | 0.89 | LNPEP (0.49) | SLC6A2LNPEPANPEPOPRM1OPRD1 | |
| SCHEMBL29619755 | 0.86 | LNPEP (0.63) | SLC6A2LNPEPANPEPOPRM1C5AR1 | |
| SCHEMBL30495881 | 0.85 | LNPEP (0.57) | SLC6A2LNPEPANPEPOPRM1OPRD1 | |
| SCHEMBL30724176 | 0.85 | SLC6A2 (0.53) | SLC6A2OPRM1OPRD1F2C5AR1 | |
| SCHEMBL30974546 | 0.85 | C5AR1 (0.60) | F2C5AR1 | |
| Angiotensin Iv SCHEMBL4322224 | 0.84 | LNPEP (0.68) | SLC6A2LNPEPANPEPF2REN | |
| Angiotensin Iv SCHEMBL4322236 | 0.84 | LNPEP (0.68) | SLC6A2LNPEPANPEPF2REN | |
| SCHEMBL31090172 | 0.84 | SLC6A2 (0.64) | SLC6A2LNPEPANPEPOPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5177015-A | Onco-developmentally regulated α-N-acetylgalactosaminyltransferase | FRED HUTCHINSON CANCER RESEARCH CENTRE (US) | 1993-01-05 | — | — | US | claimed |
| EP-0354652-A2 | Novel alpha-N-acetylgalactosaminyltransferase and method of detecting tumour cells using same | The Biomembrane Institute (US) | 1990-02-14 | — | — | EP | claimed |
| US-5300630-A | Hexapeptide glycosylated at threonine linrage | FRED HUTCHINSON CANCER RESEARCH INSTITUTE (US) | 1994-04-05 | — | — | US | disclosed |
| US-5300630-A | Hexapeptide glycosylated at threonine linrage | FRED HUTCHINSON CANCER RESEARCH INSTITUTE (US) | 1994-04-05 | — | — | US | disclosed |
| US-5177015-A | Onco-developmentally regulated α-N-acetylgalactosaminyltransferase | FRED HUTCHINSON CANCER RESEARCH CENTRE (US) | 1993-01-05 | — | — | US | disclosed |
| US-5177015-A | Onco-developmentally regulated α-N-acetylgalactosaminyltransferase | FRED HUTCHINSON CANCER RESEARCH CENTRE (US) | 1993-01-05 | — | — | US | disclosed |
| EP-0354652-A3 | NOVEL ALPHA-N-ACETYLGALACTOSAMINYLTRANSFERASE AND METHOD OF DETECTING TUMOUR CELLS USING SAME | The Biomembrane Institute (US) | 1991-07-17 | — | — | EP | disclosed |
| EP-0354652-A2 | Novel alpha-N-acetylgalactosaminyltransferase and method of detecting tumour cells using same | The Biomembrane Institute (US) | 1990-02-14 | — | — | EP | disclosed |
| EP-0354652-A2 | Novel alpha-N-acetylgalactosaminyltransferase and method of detecting tumour cells using same | The Biomembrane Institute (US) | 1990-02-14 | — | — | EP | disclosed |